Gilead Sciences, Inc. et al v. JAMP Pharma Corporation

Call to arrange a consultation

2022

T-1484-22

Pending

New PM(NOC) Regulations

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,845,553 (tenofovir alafenamide).

Counsel to:

JAMP Pharma Corporation

The decision is reported

Partner

Associate

Associate